Authors:
Sebagh, M
Debette, M
Samuel, D
Emile, JF
Falissard, B
Cailliez, V
Shouval, D
Bismuth, H
Reynes, M
Citation: M. Sebagh et al., "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection, HEPATOLOGY, 30(5), 1999, pp. 1144-1150
Authors:
Rudolph, KL
Trautwein, C
Kubicka, S
Rakemann, T
Bahr, MJ
Sedlaczek, N
Schuppan, D
Manns, MP
Citation: Kl. Rudolph et al., Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats, HEPATOLOGY, 30(5), 1999, pp. 1159-1166
Authors:
Hui, AM
Cui, X
Makuuchi, M
Li, X
Shi, YZ
Takayama, T
Citation: Am. Hui et al., Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma, HEPATOLOGY, 30(5), 1999, pp. 1167-1173
Authors:
Roncalli, M
Roz, E
Coggi, G
Di Rocco, G
Bossi, P
Minola, E
Gambacorta, M
Borzi, M
Citation: M. Roncalli et al., The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification, HEPATOLOGY, 30(5), 1999, pp. 1174-1178
Authors:
Yoshiji, H
Kuriyama, S
Hicklin, DJ
Huber, J
Yoshii, J
Miyamoto, Y
Kawata, M
Ikenaka, Y
Nakatani, T
Tsujinoue, H
Fukui, H
Citation: H. Yoshiji et al., KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells, HEPATOLOGY, 30(5), 1999, pp. 1179-1186
Authors:
Crissey, MAS
Leu, JI
De Angelis, RA
Greenbaum, LE
Scearce, LM
Kovalovich, K
Taub, R
Citation: Mas. Crissey et al., Liver-specific and proliferation-induced deoxyribonuclease I hypersensitive sites in the mouse insulin-like growth factor binding protein-1 gene, HEPATOLOGY, 30(5), 1999, pp. 1187-1197
Citation: Sb. Mustafa et al., Suppression of lipopolysaccharide-induced nitric oxide synthase expressionby platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells, HEPATOLOGY, 30(5), 1999, pp. 1206-1214
Authors:
Shima, Y
Nakao, K
Nakashima, T
Kawakami, A
Nakata, K
Hamasaki, K
Kato, Y
Eguchi, K
Ishii, N
Citation: Y. Shima et al., Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells, HEPATOLOGY, 30(5), 1999, pp. 1215-1222
Authors:
Yadav, SS
Sindram, D
Perry, DK
Clavien, PA
Citation: Ss. Yadav et al., Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway, HEPATOLOGY, 30(5), 1999, pp. 1223-1231
Authors:
Kunstle, G
Hentze, H
Germann, PG
Tiegs, G
Meergans, T
Wendel, A
Citation: G. Kunstle et al., Concanavalin A hepatotoxicity in mice: Tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation, HEPATOLOGY, 30(5), 1999, pp. 1241-1251
Citation: W. Liao et al., Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the Toll-like receptor 4, HEPATOLOGY, 30(5), 1999, pp. 1252-1256
Authors:
Petzinger, E
Wickboldt, A
Pagels, P
Starke, D
Kramer, W
Citation: E. Petzinger et al., Hepatobiliary transport of bile acid amino acid, bile acid peptide, and bile acid oligonucleotide conjugates in rats, HEPATOLOGY, 30(5), 1999, pp. 1257-1268
Authors:
McCourt, PAG
Smedsrod, BH
Melkko, J
Johansson, S
Citation: Pag. Mccourt et al., Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors, HEPATOLOGY, 30(5), 1999, pp. 1276-1286
Authors:
Cooreman, MP
van Roosmalen, VH
Morsche, RT
Sunnen, CMG
Schoondermark-Van de Ven, EME
Jansen, JBMJ
Tytgat, GNJ
de Wit, PLM
Paulij, WP
Citation: Mp. Cooreman et al., Characterization of the reactivity pattern of murine monoclonal antibodiesagainst wild-type hepatitis B surface antigen to G145R and other naturallyoccurring "a" loop escape mutations, HEPATOLOGY, 30(5), 1999, pp. 1287-1292
Authors:
Ong, JP
Barnes, DS
Younossi, ZM
Gramlich, T
Yen-Lieberman, B
Goormastic, M
Sheffield, C
Hoercher, K
Starling, R
Young, J
Smedira, N
McCarthy, P
Citation: Jp. Ong et al., Outcome of de novo hepatitis C virus infection in heart transplant recipients, HEPATOLOGY, 30(5), 1999, pp. 1293-1298
Authors:
Benhamou, Y
Bochet, M
Thibault, V
Di Martino, V
Caumes, E
Bricaire, F
Opolon, P
Katlama, C
Poynard, T
Citation: Y. Benhamou et al., Long-term incidence of hepatitis B virus resistance to lamivudine in humanimmunodeficiency virus-infected patients, HEPATOLOGY, 30(5), 1999, pp. 1302-1306
Authors:
Jamal, MM
Soni, A
Quinn, PG
Wheeler, DE
Arora, S
Johnston, DE
Citation: Mm. Jamal et al., Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States, HEPATOLOGY, 30(5), 1999, pp. 1307-1311
Authors:
Hsu, HY
Chang, MH
Liaw, SH
Ni, YH
Chen, HL
Citation: Hy. Hsu et al., Changes of hepatitis B surface antigen variants in carrier children beforeand after universal vaccination in Taiwan, HEPATOLOGY, 30(5), 1999, pp. 1312-1317
Authors:
Younossi, ZM
Singer, ME
McHutchison, JG
Shermock, KM
Citation: Zm. Younossi et al., Cost effectiveness of interferon alpha 2b combined with ribavirin for the treatment of chronic hepatitis C, HEPATOLOGY, 30(5), 1999, pp. 1318-1324
Authors:
Mizukoshi, E
Kaneko, S
Kaji, K
Terasaki, S
Matsushita, E
Muraguchi, M
Ohmoto, Y
Kobayashi, K
Citation: E. Mizukoshi et al., Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C, HEPATOLOGY, 30(5), 1999, pp. 1325-1331